Please assess the completion status of the following clinical trial:

Trial Title: A Study to Evaluate the Safety of FluMist in Healthy Children and Healthy Adults

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* 5-49 years of age~* Members of the Kaiser Permanente (KP) Health Care Plan within KP of Northern California, KP of Colorado, and KP of Hawaii~Exclusion Criteria:~* Must not have had any high risk underlying medical conditions, includig asthma

- Gender: ALL
- Minimum Age: 5 Years
- Maximum Age: 49 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: None): 5-8 years of age, estimated to be approximately 4,000 new FluMist vaccinees per season
- 2 (Type: None): 9-17 years of age, estimated to be approximately 5,000 new FluMist vaccinees per season
- 3 (Type: None): 18-49 years of age, estimated to be approximately 6,000 new FluMist vaccinees per season.

Based on this trial design, predict the completion outcome and termination type (if applicable).